Advantages and disadvantages of combined mucolytic therapy in children
https://doi.org/10.21508/1027-4065-2019-64-6-114-118
Abstract
The article discusses in detail advantages and disadvantages of combined mucolytic therapy in children, the requirements for the composition and purpose of such drugs. Such drug as Ascoril expectorant is considered to be a successful combination, pathogenetic mechanisms of the synergistic action of its components. The clinical experience of Ascoril expectorant application demonstrated its high clinical efficacy and safety, which makes it the first choice for bronchitis, mild bronchial obstruction in outpatient pediatric practice
About the Authors
Yu. L. Mizernitsky
Research and Clinical Institute for Pediatrics named after Academician Yu.E. Veltischev of the Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation; Clinical Institute of children’s health named After N. F. Filatov, FIRST Moscow state medical UNIVERSITY. I. M. Sechenova Ministry of health of Russia (Sechenov University)
Russian Federation
Russian Federation
Moscow
M. D. Shakhnazarova
Research and Clinical Institute for Pediatrics named after Academician Yu.E. Veltischev of the Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation; Clinical Institute of children’s health named After N. F. Filatov, FIRST Moscow state medical UNIVERSITY. I. M. Sechenova Ministry of health of Russia (Sechenov University)
Russian Federation
Russian Federation
Moscow
References
1. Mizernitsky Yu.L., Melnikova I.M., Udaltsova E.V. Differential diagnosis of prolonged and prolonged cough in children. Consilium medicum (Bolezni organov dy`xaniya) 2017; 19(11.1): 7–16 (in Russ.)
2. Mizernitsky Yu.L., Melnikova I.M. Mucolytic and expectorant pharmacotherapy for lung diseases in children. Moscow: Medpraktika-M, 2013; 120 (in Russ.)
3. Zajcev A.A., Sinopal’nikov A.I. Rational pharmacotherapy of acute respiratory viral infections. Consilium Medicum 2008; 10: 80–86 (in Russ.)
4. Zajceva S.V., Lokshina E.E., Zajceva O.V., Muratazaeva O.A., Kuznecov G.B., Ravshanova L.S. et al. The rational choice of drugs for the treatment of cough in children with acute diseases of the lower respiratory tract. Pediatriya. Zhurnal im. G.N. Speranskogo (Pediatria. Journal named after G.N. Speransky) 2012; 91(5): 79–85 (in Russ.)
5. Majima Y., Kurono Y., Hirakawa K., Ichimura K., Haruna S., Suzaki H. et al. Efficacy of combined treatment with S-carboxymethylcysteine (carbocysteine) and clarithromycin in chronic rhinosinusitis patients without nasal polyp or with small nasal polyp. Auris Nasus Larynx 2012; 39(1): 38–47. DOI: 10.1016/j.anl.2011.04.015
6. Melnikova I.M., Mizernitsky Yu.L. Combined expectorant drugs of plant origin in pediatric practice. Medicinskii Sovet 2018; 2: 93–97 (in Russ.) DOI: 10.21518/2079-701X-2018-2-93-97.
7. Mizernitsky Yu.L., Sulajmanov Sh.A. Modern combined herbal preparations in the practice of a pulmonologist. Medicinskii sovet 2019; 11: 82–88 (in Russ.) DOI: 10.21518/2079-701X-2019-11-82-88.
8. Mizernitsky Yu.L., Melnikova I.M. The role of combination mucolytic therapy in infectious and inflammatory diseases of the respiratory system in children. Medicinskii sovet 2019; 11: 56–59 (in Russ.) DOI: 10.21518/2079-701X-2019-11-56-59.
9. Mizernitsky Yu.L. Expectorant and mucolytic agents in the treatment of bronchopulmonary diseases in children. In: A.D. Caregorodcev, V.A. Tabolin (eds). Vol.1. Moscow: MEDPRAKTIKA-M, 2002; 123–140 (in Russ.)
10. Okovityj S.V., Anisimova N.A. Pharmacological approaches to antitussive therapy. RMZh. Bolezni dyhatel’nyh putei 2011; 23: 1450–1457 (in Russ.)
11. Sokolova L.V. Mizernitsky Yu.L., Sorokina E.V., Grjazina O.V. The use of the drug Ascoril in children with respiratory diseases. Mat. scientific and practical conf. pediatricians of Russia « Pharmacotherapy of allergic diseases in children». Voprosy sovremennoi pediatrii 2002; 1(Suppl 1): 45 (in Russ.)
12. Vasil’eva O.S., Gushhina E.E. Ascoril in the treatment of diseases of the respiratory system: new about the known. RMZh 2012; 26: 1344–1346 (in Russ.)
13. Kljachkina I.L., Sinopal’nikov A.I. Fixed combinations of mucoactive drugs in a cough treatment program. Prakticheskaya pul’monologiya 2015; 1: 74–82 (in Russ.)
14. Klyachkina I.L. Treatment of cough with ARTI and influence. RMZh 2012; 1: 278–285 (in Russ.)
15. Shmeleva N.V. The use of Ascoril mucoregulator for respiratory diseases. Terapevticheskii arhiv 2012; 10: 86–90 (in Russ.)
16. Knjazheskaja N.P., Bokov E.V., Tatarskij A.R. The combined drug Ascoril in the treatment of cough and bronchial obstruction. RMZh 2013; 7: 368 (in Russ.)
17. Meshherjakov V.V., Sinevich O.Yu., Pavlinova E.B., Rjabikova D.A., Kashtanova V.K., Safonova T.I. et al. The effectiveness and safety of the oral form of Salbutamol (as exemplified by Ascoril) in the treatment of exacerbations of bronchial asthma in children. Pediatriya. Zhurnal im. G.N. Speranskogo (Pediatria. Journal named after G.N. Speransky) 2003; 82(6): 68–70 (in Russ.)
18. Drozdov V.N., Serebrova S.Yu., Vorob’jova V.A., Starodubcev A.K., Dobrovol’skij O.V. Modern possibilities for the treatment of respiratory diseases in pediatric practice. Medicinskii sovet 2018; 17: 132–136 (in Russ.) DOI: 10.21518/2079-701X-2018-17-132-136.
19. Geppe N.A., Seliverstova N.A., Malyshev V.S. Bronchophonographic examination of the lungs in patients with early bronchial asthma. Pul’monologiya 2008; 3: 38–41 (in Russ.)
20. Geppe N.A., Seliverstova N.A., Utjusheva M.G. Modern methods of treating cough in acute respiratory infections in children. Jeffektivnaya farmakoterapiya. Pul’monologiya i otorinolaringologiya 2011; 2: 2–6 (in Russ.)
21. Kljuchnikov S.O. Treatment of cough with acute respiratory viral infections in frequently ill children. RMZh 2012; 2: 68–71 (in Russ.)
Review
For citations:
Mizernitsky Yu.L., Shakhnazarova M.D. Advantages and disadvantages of combined mucolytic therapy in children. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2019;64(6):114-118. (In Russ.) https://doi.org/10.21508/1027-4065-2019-64-6-114-118
Views:
1108
Email this article 